Verified email-pattern data for Insteps Bv is currently limited. You can still use the company insights and contact sections below.
Stroke is a major contributor to both death and disability in Europe. Thrombectomy, a crucial treatment for severe strokes caused by large vessel blockages, faces significant challenges in development and implementation. With a mere 10% success rate in introducing new stroke treatments, there’s a pressing need for faster, more efficient, and cost-effective solutions. inSteps introduces an advanced in-silico modelling platform designed for developing, testing, and evaluating endovascular devices. inSteps offers a solution to accelerate the adoption of life-saving treatments for millions of people affected by acute ischemic strokes, thereby addressing a critical healthcare need.
inSteps' unique advanced in-silico modelling platform is a sophisticated computer-based system designed to simulate and model complex medical processes and scenarios, such as stroke and its treatment. The platform is employed in service of device manufacturers of stent-retrievers to test different stent designs across various patient anatomies and clot types before embarking on costly clinical trials. Our in-silico models enable the thorough evaluation and improved implementation of novel treatments for different sub-populations.
Born from the University of Amsterdam, inSteps was founded in 2023 by Prof. Henk Marquering, Dr. Praneeta Konduri, Dr. Nerea Arrarte Terreros and Dr. Thomas Kerbusch. They hail from the Departments of Radiology & Nuclear Medicine, Biomedical Engineering & Physics at Amsterdam UMC-AMC.
The mission of inSteps is to support device manufacturers (business-to-business services) in designing, testing, and launching new stroke treatment devices to provide acute ischemic stroke patients with better life-saving treatments.
The company offers 4 different modules:
Module 1 – Virtual stroke population.
Module 2 – Finite element thrombectomy models.
Module 3 – Stroke disease model.
Module 4 – In-silico trial platform
Company Details
- Employees
- 3
- Founded
- -
- Address
- Meibergdreef 9, Amsterdam,north Holland 1105 Az,netherlands
- Industry
- Medical Equipment Manufacturing
- Website
- http://www.insteps.com
- HQ
- Amsterdam, North Holland
Insteps Bv Questions
inSteps BV's website is http://www.insteps.com
inSteps BV's LinkedIn profile is https://nl.linkedin.com/company/insteps-bv
inSteps BV has
3 employees.
View email and phone details for 3
employees at inSteps BV.
inSteps BV's industry is
Medical Equipment Manufacturing
inSteps BV's top competitors are
Stemx Bio,
Twente Medical Optics,
Neurotidal Diagnostics,
Hellor&d,
Nicolab,
Artic Technologies,
Nestegg Labs,
Cloudcuddle,
Trianect,
Traumamed Solutions Ltd.
inSteps BV's categories are Medical Equipment Manufacturing
inSteps BV's founding year is 2023
Explore related pages
Related company profiles:
Top inSteps BV Employees
-
Emiel den Haan
Associate Scientist / Biomedical Engineer
Katwijk, South Holland, Netherlands, Netherlands -
Henk Marquering
Professor Of Radiology, In Particular Translational Artificial Intelligence At Amsterdam University Medical Centers
The Randstad, Netherlands, Netherlands2nico-lab.com, hotmail.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.